Protagonist Therapeutics, Inc Income Taxes Receivable, Current
Protagonist Therapeutics, Inc (PTGX) had Income Taxes Receivable, Current of AUD 3.80 million as of 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2023-03-15
- 2022-12-31: Income Taxes Receivable, Current 3.80M AUD.
- 2020-12-31: Income Taxes Receivable, Current 1.40M AUD.
- 2018-09-30: Income Taxes Receivable, Current 1.60M AUD.
- 2018-06-30: Income Taxes Receivable, Current 3.00M AUD.
AUD
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2022-12-31 | 3.80M AUD 10-K · filed 2023-03-15 |
| 2020-12-31 | 1.40M AUD 10-K · filed 2023-03-15 |
| 2018-09-30 | 1.60M AUD 10-Q · filed 2018-11-06 |
| 2018-06-30 | 3.00M AUD 10-Q · filed 2018-08-07 |
| 2018-03-31 | 2.50M AUD 10-Q · filed 2018-05-09 |
| 2017-12-31 | 1.70M AUD 10-Q · filed 2018-11-06 |
USD
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2022-06-30 | $2.65M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.88M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.79M 10-K · filed 2023-03-15 |
| 2021-09-30 | $1.87M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $2.78M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $1.82M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $1.08M 10-K · filed 2022-02-28 |
| 2020-09-30 | $535.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $276.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $153.00K 10-Q · filed 2020-05-07 |
| 2019-09-30 | $173.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.42M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $1.88M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.43M 10-K · filed 2020-03-10 |
| 2018-09-30 | $1.16M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.19M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.92M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.35M 10-K · filed 2019-03-12 |
| 2016-12-31 | $2.24M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |